GlassScriptPhysician profile
Janna Lister
NPI 1528478344
$1,575.23
in general payments reported to CMS, 2019-2025
21 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $272 · 2024: $815 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $512.10 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $186.21 | 2023-2025 | |
| Exact Sciences Corporation | $123.28 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $118.85 | 2023-2025 | Veozah |
| Pfizer INC. | $94.82 | 2023-2025 | |
| Lilly USA, LLC | $86.26 | 2023-2025 | Mounjaro, Zepbound |
| Phathom Pharmaceuticals, INC. | $75.95 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $64.83 | 2024 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $61.40 | 2023-2024 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $53.72 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.47 | 2024 | Ofev |
| Sumitomo Pharma America, INC. | $29.15 | 2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.13 | 2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $15.89 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $15.71 | 2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.41 | 2023 | Jornay Pm |
| Medtronic, INC. | $15.01 | 2025 | Minimed 780g |
| Inspire Medical Systems, INC. | $14.51 | 2023 | Inspire |
| Amgen INC. | $14.07 | 2024 | Otezla, Repatha |
| Cranial Technologies, INC | $13.83 | 2024 | Doc Band |
| Axsome Therapeutics, INC. | $13.63 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janna Lister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.